Romeo, Baby Boy .
HRN: 24-67-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/24/2024
03/31/2024
IV
30mg
OD
PPROM
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes